

IntronX is a biotechnology company developing small molecule therapeutics that target RNA structure and splicing. Built on the world-class research of the Pyle Laboratory at Yale University, our work is driven by deep expertise in RNA biology and a mission to address diseases at the molecular level. The logo reflects this vision: clean, modern typography paired with a bold yellow "X" that symbolizes innovation and the precise intersection of science and medicine. At IntronX, we're advancing the next generation of RNA-targeted therapies to transform how genetic and rare diseases are treated.